These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR). Berger PB; Holmes DR; Ohman EM; O'Hanesian MA; Murphy JG; Schwartz RS; Serruys PW; Faxon DP J Am Coll Cardiol; 1996 Jan; 27(1):1-7. PubMed ID: 8522681 [TBL] [Abstract][Full Text] [Related]
9. Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty. Guiteras-Val P; Varas-Lorenzo C; Garcia-Picart J; Martí-Claramunt V; Augé-Sanpera JM Am J Cardiol; 1999 Mar; 83(6):868-74. PubMed ID: 10190401 [TBL] [Abstract][Full Text] [Related]
10. Are there differences in late outcome after PTCA for angina pectoris after non-Q wave vs Q wave myocardial infarction? Brueren BR; Rosseel MP; Bal ET; Mast EG; Ernst JM; Suttorp MJ; Kelder JC; Plokker HW Eur Heart J; 1997 Dec; 18(12):1903-12. PubMed ID: 9447318 [TBL] [Abstract][Full Text] [Related]
12. Prolonged dilation with an autoperfusion balloon catheter for refractory acute occlusion related to percutaneous transluminal coronary angioplasty. van der Linden LP; Bakx AL; Sedney MI; Buis B; Bruschke AV J Am Coll Cardiol; 1993 Oct; 22(4):1016-23. PubMed ID: 8409036 [TBL] [Abstract][Full Text] [Related]
14. Long-term angiographic follow up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty. Ernst SM; van der Feltz TA; Bal ET; van Bogerijen L; van den Berg E; Ascoop CA; Plokker HW Br Heart J; 1987 Mar; 57(3):220-5. PubMed ID: 2952153 [TBL] [Abstract][Full Text] [Related]
15. The Subcutaneous Heparin and Angioplasty Restenosis Prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome. Brack MJ; Ray S; Chauhan A; Fox J; Hubner PJ; Schofield P; Harley A; Gershlick AH J Am Coll Cardiol; 1995 Oct; 26(4):947-54. PubMed ID: 7560622 [TBL] [Abstract][Full Text] [Related]
16. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design. Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102 [TBL] [Abstract][Full Text] [Related]
17. Results of percutaneous transluminal coronary angioplasty for angina pectoris early after acute myocardial infarction. Holt GW; Gersh BJ; Holmes DR; Vlietstra RE; Bresnahan JF; Reeder GS; Smith HC Am J Cardiol; 1988 Jun; 61(15):1238-42. PubMed ID: 2967634 [TBL] [Abstract][Full Text] [Related]
18. Five years of angiographic and clinical follow-up after successful percutaneous transluminal coronary angioplasty. Guiteras P; Tomas L; Varas C; Augé JM; Masotti M; Crexells C; Oriol A Eur Heart J; 1989 Dec; 10 Suppl G():42-8. PubMed ID: 2627948 [TBL] [Abstract][Full Text] [Related]
19. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. Pfisterer M; Rickenbacher P; Kiowski W; Müller-Brand J; Burkart F J Am Coll Cardiol; 1993 Nov; 22(5):1446-54. PubMed ID: 8227804 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of the substitution of nonangiographic end points (death, acute myocardial infarction, coronary bypass and/or repeat angioplasty) for follow-up coronary angiography in evaluating the success of coronary angioplasty in patients with angina pectoris. Weintraub WS; Ghazzal ZM; Douglas JS; Morris DC; King SB Am J Cardiol; 1998 Feb; 81(4):382-6. PubMed ID: 9485123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]